{"id":"https://openalex.org/W2160102993","doi":"https://doi.org/10.1111/j.1463-1326.2006.00633.x","title":"Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy","display_name":"Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy","publication_year":2006,"publication_date":"2006-08-04","ids":{"openalex":"https://openalex.org/W2160102993","doi":"https://doi.org/10.1111/j.1463-1326.2006.00633.x","mag":"2160102993","pmid":"https://pubmed.ncbi.nlm.nih.gov/17587394"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2006.00633.x","doi":"https://doi.org/10.1111/j.1463-1326.2006.00633.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2006.00633.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020648679","display_name":"Paulos Berhanu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Berhanu","raw_affiliation_strings":["Division of Diabetes, Endocrinology and Metabolism, Wayne State University School of Medicine, Detroit, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Diabetes, Endocrinology and Metabolism, Wayne State University School of Medicine, Detroit, MI, USA","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064632809","display_name":"Alfonso P\u00e9rez","orcid":"https://orcid.org/0000-0002-3141-1086","observed_orcids":["https://orcid.org/0000-0002-3141-1086"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Perez","raw_affiliation_strings":["Takeda Global Research and Development Center, Lincolnshire, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research and Development Center, Lincolnshire, IL, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101877730","display_name":"Shawn S. Yu","orcid":"https://orcid.org/0000-0003-1951-2949","observed_orcids":["https://orcid.org/0000-0003-1951-2949"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Yu","raw_affiliation_strings":["Takeda Global Research and Development Center, Lincolnshire, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research and Development Center, Lincolnshire, IL, USA","institution_ids":["https://openalex.org/I4210140176"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":1.3574,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.83661586,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"9","issue":"4","first_page":"512","last_page":"520"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9950000047683716},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9419999718666077},{"id":"https://openalex.org/keywords/insulin-dose-reduction","display_name":"insulin dose reduction","score":0.7459999918937683},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.7200000286102295},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8050000071525574},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9419999718666077},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.7919999957084656},{"id":"https://openalex.org/keywords/ldl-particle-size","display_name":"LDL particle size","score":0.8140000104904175},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8119999766349792},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9620000123977661},{"id":"https://openalex.org/keywords/edema","display_name":"edema","score":0.7689999938011169},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.46399998664855957},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5339999794960022},{"id":"https://openalex.org/keywords/uncontrolled-diabetes","display_name":"uncontrolled diabetes","score":0.6570000052452087},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.7749999761581421},{"id":"https://openalex.org/keywords/insulin-sensitizers","display_name":"insulin sensitizers","score":0.6669999957084656},{"id":"https://openalex.org/keywords/ldl-particle-number","display_name":"LDL particle number","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.988501787185669},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8368988037109375},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7940934896469116},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7121559381484985},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6830103397369385},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6785058975219727},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5864078998565674},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5631921291351318},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.5547081828117371},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5539396405220032},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4964476227760315},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.44589048624038696},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3592239022254944},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.2943413257598877},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1463-1326.2006.00633.x","doi":"https://doi.org/10.1111/j.1463-1326.2006.00633.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2006.00633.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:17587394","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17587394","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W40400977","https://openalex.org/W74574975","https://openalex.org/W131917179","https://openalex.org/W1975588287","https://openalex.org/W2000970191","https://openalex.org/W2007914298","https://openalex.org/W2008742028","https://openalex.org/W2013136359","https://openalex.org/W2015279471","https://openalex.org/W2017421207","https://openalex.org/W2033125833","https://openalex.org/W2065323334","https://openalex.org/W2093894290","https://openalex.org/W2099378532","https://openalex.org/W2102675827","https://openalex.org/W2103962195","https://openalex.org/W2105362864","https://openalex.org/W2107353084","https://openalex.org/W2111184067","https://openalex.org/W2123946565","https://openalex.org/W2132984693","https://openalex.org/W2136638379","https://openalex.org/W2138851319","https://openalex.org/W2140603676","https://openalex.org/W2159969745","https://openalex.org/W2164597700","https://openalex.org/W2323262681","https://openalex.org/W2337454357","https://openalex.org/W4238183455","https://openalex.org/W4240449862","https://openalex.org/W4250413101","https://openalex.org/W4254695749","https://openalex.org/W6658302128"],"related_works":["https://openalex.org/W2000970191","https://openalex.org/W2385736462","https://openalex.org/W2017030986","https://openalex.org/W40400977","https://openalex.org/W2366606767","https://openalex.org/W2349430412","https://openalex.org/W2018312537","https://openalex.org/W2037447341","https://openalex.org/W2380420525","https://openalex.org/W2079614274"],"abstract_inverted_index":{"AIM:":[0],"The":[1],"aim":[2],"of":[3,15,100],"this":[4,47],"randomized":[5],"placebo-controlled":[6],"study":[7,127],"was":[8],"to":[9,80,106,130,154,223],"evaluate":[10],"the":[11,109],"safety":[12],"and":[13,75,107,230,248,271],"efficacy":[14],"pioglitazone":[16,84,132,156],"administered":[17],"alone":[18],"or":[19,85,92],"in":[20,24,33,87,259,275],"combination":[21,43,61,88,260,285],"with":[22,35,42,53,60,83,89,91,261,277,284],"metformin":[23,95,104],"reducing":[25],"insulin":[26,67,118,135,159,262,268],"dosage":[27],"requirements":[28,120,270],"for":[29],"improved":[30,264,272],"glycaemic":[31,265],"control":[32],"patients":[34,52,101,242,276],"type":[36,278],"2":[37,121,279],"diabetes":[38,280],"previously":[39,281],"poorly":[40,282],"controlled":[41,283],"therapy.":[44,96,286],"METHODS:":[45],"In":[46],"multicentre,":[48],"double-blind":[49],"study,":[50],"222":[51],"haemoglobin":[54],"A1c":[55],"(HbA(1c))>8.0%":[56],"at":[57,147],"screening":[58],"treated":[59],"therapy":[62,68,263],"initially":[63],"were":[64,77,102],"given":[65],"titrated":[66],"(to":[69],"fasting":[70],"plasma":[71],"glucose":[72],"<140":[73],"mg/dl)":[74],"then":[76],"randomly":[78],"assigned":[79],"20-week":[81],"treatment":[82,124],"placebo":[86,255],"insulin,":[90],"without":[93],"concurrent":[94],"More":[97,240],"than":[98,254],"98%":[99],"taking":[103],"prior":[105],"during":[108],"study.":[110],"RESULTS:":[111],"Pioglitazone":[112,187,258],"significantly":[113,189],"reduced":[114,133,157,267],"(p":[115,140],"<":[116,141],"0.05)":[117],"dose":[119,269],"weeks":[122],"after":[123],"initiation.":[125],"At":[126],"end":[128],"relative":[129],"baseline,":[131],"daily":[134,158],"dosages":[136,160],"by":[137,161],"12.0":[138],"units":[139,146,163],"0.001),":[142],"a":[143],"21.5%":[144],"(12.0/55.8":[145],"baseline)":[148],"group":[149],"mean":[150,172,176,196,232],"average":[151],"reduction.":[152],"Relative":[153],"placebo,":[155,182],"12.7":[162],"[95%":[164],"confidence":[165],"interval":[166],"[CI]:":[167],"-17.5,":[168],"-8.0],":[169],"while":[170],"improving":[171],"HbA(1c)":[173,177],"levels":[174,194,205],"[adjusted":[175,195],"change:":[178],"pioglitazone,":[179],"-1.6%":[180],"vs.":[181,246,252],"-1.4%":[183],"(not":[184],"statistically":[185],"different)].":[186],"also":[188],"increased":[190,231],"high-density":[191],"lipoprotein":[192,212],"cholesterol":[193],"difference:":[197],"+4.5":[198],"(95%":[199],"CI:":[200],"2.6-6.5)":[201],"mg/dl],":[202,209],"decreased":[203],"triglyceride":[204],"[-43.9":[206],"(-69.2,":[207],"-18.6)":[208],"shifted":[210],"low-density":[211],"(LDL)":[213],"particle":[214,234],"concentrations":[215],"from":[216],"small":[217],"[pattern":[218,225],"B,":[219],"-13.6%":[220],"(-17.7%,":[221],"-9.5%)]":[222],"large":[224],"A,":[226],"+15.1%":[227],"(10.8%,":[228],"19.5%)]":[229],"LDL":[233],"size":[235],"[+3.8":[236],"(2.6,":[237],"4.9)":[238],"A].":[239],"pioglitazone-treated":[241],"experienced":[243],"oedema":[244],"(9.0":[245],"4.5%)":[247],"weight":[249],"gain":[250],"(9.1":[251],"2.7%)":[253],"patients.":[256],"CONCLUSIONS:":[257],"control,":[266],"lipid":[273],"profiles":[274]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}